[Diagnosis and therapy of ergotism following the use of heparin-DHE in thrombosis prevention].
Vasospastic complications have been reported in five patients following the use of heparin-dihydroergotamine for thrombo-embolic prophylaxis. The most important diagnostic procedure is angiography, which shows characteristic findings. Intraarterial prostaglandin is a promising form of treatment. Experience with two patients is reported.
Wiesmann
W
W
Institut für Klinische Radiologie der Westfälischen Wilhelms-Universität Münster.
Peters
P E
PE
Irskens
U
U
Schwering
H
H
D000293:Adolescent; D000328:Adult; D002648:Child; D004087:Dihydroergotamine / Q000009:adverse effects* / Q000627:therapeutic use; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D004881:Ergotism / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D006493:Heparin / Q000009:adverse effects* / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight; D006801:Humans; D008297:Male; D011859:Radiography; D013923:Thromboembolism / Q000517:prevention & control*
D004338:Drug Combinations; D006495:Heparin, Low-Molecular-Weight; C031388:heparin-dihydergot; D004087:Dihydroergotamine; D006493:Heparin
Diagnostik und Therapie des Ergotismus nach Heparin-DHE-Thromboseprophylaxe.